REGULON, INC.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 08, 2016 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 270 Total Citation Count
- Jun 27, 1997 Earliest Filing
- 6 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9278067 Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexesMay 22, 13Mar 08, 16[A61K, C12N]
6511676 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomesNov 05, 99Jan 28, 03[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0258,139 METHODS FOR TREATMENT OF CANCER USING LIPOPLATINAbandonedAug 13, 12Sep 17, 15[A61K, A61N]
2012/0183,596 Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome ComplexesAbandonedJul 02, 10Jul 19, 12[A61K, A61P]
2009/0280,164 THERAPY FOR HUMAN CANCERS USING CISPLATIN AND OTHER DRUGS OR GENES ENCAPSULATED INTO LIPOSOMESAbandonedJun 05, 08Nov 12, 09[A61K]
7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomesExpiredJan 23, 03Jul 01, 08[A61K]
2003/0072,794 Encapsulation of plasmid DNA (lipogenes.TM.) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexesAbandonedJun 08, 01Apr 17, 03[A61K, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.